295 related articles for article (PubMed ID: 10715162)
21. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
[TBL] [Abstract][Full Text] [Related]
23. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
Blanchet PJ; Konitsiotis S; Whittemore ER; Zhou ZL; Woodward RM; Chase TN
J Pharmacol Exp Ther; 1999 Sep; 290(3):1034-40. PubMed ID: 10454475
[TBL] [Abstract][Full Text] [Related]
24. Parallel synthesis of a series of subtype-selective NMDA receptor antagonists.
Gregory TF; Wright JL; Wise LD; Meltzer LT; Serpa KA; Konkoy CS; Whittemore ER; Woodward RM
Bioorg Med Chem Lett; 2000 Mar; 10(6):527-9. PubMed ID: 10741546
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.
Murali Dhar TG; Nagarathnam D; Marzabadi MR; Lagu B; Wong WC; Chiu G; Tyagarajan S; Miao SW; Zhang F; Sun W; Tian D; Shen Q; Zhang J; Wetzel JM; Forray C; Chang RS; Broten TP; Schorn TW; Chen TB; O'Malley S; Ransom R; Schneck K; Bendesky R; Harrell CM; Vyas KP
J Med Chem; 1999 Nov; 42(23):4778-93. PubMed ID: 10579841
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.
Wang Y; Konkoy CS; Ilyin VI; Vanover KE; Carter RB; Weber E; Keana JF; Woodward RM; Cai SX
J Med Chem; 1998 Jul; 41(14):2621-5. PubMed ID: 9651166
[TBL] [Abstract][Full Text] [Related]
27. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
[TBL] [Abstract][Full Text] [Related]
28. Subtype-selective N-methyl-D-aspartate receptor antagonists: benzimidazalone and hydantoin as phenol replacements.
Schelkun RM; Yuen PW; Serpa K; Meltzer LT; Wise LD; Whittemore ER; Woodward RM
J Med Chem; 2000 May; 43(9):1892-7. PubMed ID: 10794706
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and pharmacology of 3-isoxazolol amino acids as selective antagonists at group I metabotropic glutamic acid receptors.
Madsen U; Bräuner-Osborne H; Frydenvang K; Hvene L; Johansen TN; Nielsen B; Sánchez C; Stensbøl TB; Bischoff F; Krogsgaard-Larsen P
J Med Chem; 2001 Mar; 44(7):1051-9. PubMed ID: 11297452
[TBL] [Abstract][Full Text] [Related]
31. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
[TBL] [Abstract][Full Text] [Related]
32. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
Coughenour LL; Cordon JJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
[TBL] [Abstract][Full Text] [Related]
33. Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
Hess SD; Daggett LP; Crona J; Deal C; Lu CC; Urrutia A; Chavez-Noriega L; Ellis SB; Johnson EC; Veliçelebi G
J Pharmacol Exp Ther; 1996 Aug; 278(2):808-16. PubMed ID: 8768735
[TBL] [Abstract][Full Text] [Related]
34. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
[TBL] [Abstract][Full Text] [Related]
35. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
36. Remifentanil directly activates human N-methyl-D-aspartate receptors expressed in Xenopus laevis oocytes.
Hahnenkamp K; Nollet J; Van Aken HK; Buerkle H; Halene T; Schauerte S; Hahnenkamp A; Hollmann MW; Strümper D; Durieux ME; Hoenemann CW
Anesthesiology; 2004 Jun; 100(6):1531-7. PubMed ID: 15166575
[TBL] [Abstract][Full Text] [Related]
37. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
[TBL] [Abstract][Full Text] [Related]
38. Discovery of subtype-selective NMDA receptor ligands: 4-benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists.
Wright JL; Gregory TF; Boxer PA; Meltzer LT; Serpa KA; Wise LD
Bioorg Med Chem Lett; 1999 Oct; 9(19):2815-8. PubMed ID: 10522697
[TBL] [Abstract][Full Text] [Related]
39. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
Coughenour LL; Barr BM
J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]